Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Korro Bio, Inc. (KRRO) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Korro Bio, Inc. (KRRO), most recent 12 months reported: revenue $2.38M, net loss $106.64M, free cash flow -$68.27M. Latest balance sheet on file: liquid cash $115.04M. From SEC filings. Others in Pharmaceutical Preparations: BIO ESSENCE CORP. · Traws Pharma, Inc. · PMGC HOLDINGS INC. · VISTAGEN THERAPEUTICS, INC. · NORTHWEST BIOTHERAPEUTICS INC · CYCLERION THERAPEUTICS, INC. · Dianthus Therapeutics, Inc. /DE/ · ORAMED PHARMACEUTICALS INC.

Stock screener

Watchlist